January 31, 2022
| The Honorable Charles Schumer | The Honorable Nancy Pelosi |
| Majority Leader | Speaker |
| U.S. Senate | U.S. House of Representatives |
| Washington, DC 20510 | Washington, DC 20515 |
| The Honorable Mitch McConnell | The Honorable Kevin McCarthy |
| Minority Leader | Minority Leader |
| U.S. Senate | U.S. House of Representatives |
| Washington, DC 20510 | Washington, DC 20515 |
RE: Establishing a Pathway for Comprehensive Telehealth Reform
Dear Congressional Leaders:
Thank you for your leadership in expanding access to virtual care during the COVID-19 public health emergency (PHE). This access has been transformational – Americans now expect that the future of our health care system includes telehealth as a key way to access health care services. Health care providers across the nation have made substantial investments in new technologies to safely treat patients during the pandemic. Now, as we work to overcome the latest COVID-19 surge, providers and health systems are preparing to meet the health care demands of the future and need leadership from Congress in charting a path forward with respect to permanent comprehensive telehealth reform.
Explore Related Content
Federal Policy Resource
Analysis: Final 2021 Medicare Physician Payment and Quality Reporting Changes
Federal Policy Resource
Analysis: Final 2022 Medicare Physician Payment and Quality Reporting Changes
Federal Policy Resource
Analysis: Proposed 2022 Medicare Physician Payment and Quality Reporting Changes
Federal Policy Resource
GovChat Live: Review of the 2022 Medicare PFS proposed rule
Federal Policy Resource
MGMA 2018 Regulatory Burden Report
Federal Policy Resource
MGMA Annual Regulatory Burden Report - 2019
Federal Policy Resource
MGMA in Washington: 2021 Year in Review
More Advocacy Letters
Advocacy Letter
MGMA to DEA: Issue proposed telehealth rule (April 2, 2024)
Advocacy Letter
MGMA letter to Congress on LDT proposed rule (March 20, 2024)
Advocacy Letter
March 14, 2024 - MGMA urges permanent telehealth reform
Advocacy Letter
December 4, 2023: MGMA comments on proposed LDT rule
Advocacy Letter
November 13, 2023: MGMA comments on Section 504
Advocacy Letter
November 7, 2023: MGMA feedback on Senate healthcare package
Advocacy Letter
November 1, 2023: MGMA requests pause on LDT rulemaking
Advocacy Letter
October 31, 2023: MGMA urges budget neutrality reforms
